| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | NEUTRAL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.95▲ | 8.99▼ | 9.02▼ | 8.91▲ | 9.21▼ |
| MA10 | 8.94▲ | 9.05▼ | 9.00▼ | 8.84▲ | 9.35▼ |
| MA20 | 8.96▲ | 9.00▼ | 8.93▲ | 9.19▼ | 9.84▼ |
| MA50 | 9.05▼ | 8.94▲ | 8.88▲ | 9.48▼ | 8.96▼ |
| MA100 | 9.01▼ | 8.88▲ | 9.05▼ | 9.82▼ | 13.92▼ |
| MA200 | 8.93▲ | 9.15▼ | 9.20▼ | 8.40▲ | 30.02▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | -0.015▼ | 0.005▲ | 0.004▲ | -0.119▼ |
| RSI | 47.298▼ | 48.982▼ | 51.312▲ | 46.379▼ | 45.898▼ |
| STOCH | 62.889 | 30.537 | 56.787 | 59.235 | 23.489 |
| WILL %R | -44.000 | -68.493 | -45.455 | -60.753 | -78.144▼ |
| CCI | 44.216 | -77.483 | -3.466 | 16.388 | -88.909 |
|
Thursday, February 12, 2026 02:04 PM
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced ...
|
|
Wednesday, January 21, 2026 08:59 AM
Prothena (PRTA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...
|
|
Friday, December 12, 2025 01:05 PM
DUBLIN--(BUSINESS WIRE)-- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 8.85 | 9.24 | 8.845 | 8.96 | 308,607 |
| 12/02/26 | 8.93 | 9.04 | 8.72 | 8.85 | 351,722 |
| 11/02/26 | 9.01 | 9.09 | 8.65 | 8.93 | 271,115 |
| 10/02/26 | 8.81 | 9.12 | 8.77 | 8.96 | 329,528 |
| 09/02/26 | 8.90 | 9.04 | 8.59 | 8.86 | 356,096 |
| 06/02/26 | 8.58 | 8.99 | 8.56 | 8.91 | 581,028 |
| 05/02/26 | 8.86 | 9.045 | 8.23 | 8.35 | 518,973 |
| 04/02/26 | 8.77 | 9.04 | 8.48 | 8.89 | 451,843 |
| 03/02/26 | 8.90 | 9.05 | 8.61 | 8.78 | 280,865 |
| 02/02/26 | 8.79 | 8.95 | 8.39 | 8.91 | 556,687 |
|
|
||||
|
|
||||
|
|